|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
T2 Biosystems, Inc. (TTOO) |
|
|
$0.17 0.00 (0.00%) as of 4:30 Thu 10/12
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
16,340,000 |
Market
Cap: |
2.84(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.0623 - $0.5911 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2 Panel, which detect SARS-CoV-2, the coronavirus in patients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
48,345,798 |
48,364,599 |
Total Sell Value |
$0 |
$0 |
$12,851,221 |
$12,864,540 |
Total People Sold |
0 |
0 |
1 |
5 |
Total Sell Transactions |
0 |
0 |
8 |
18 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cumming John W |
Director |
|
2021-07-01 |
4 |
AS |
$1.16 |
$21,091 |
D/D |
(18,182) |
50,852 |
|
-33% |
|
Elsbree David B |
Director |
|
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,454 |
170,723 |
|
- |
|
Mcdonough John |
Director |
|
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,454 |
534,568 |
|
- |
|
Liebman Seymour |
Director |
|
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,454 |
129,639 |
|
- |
|
Cumming John W |
Director |
|
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,454 |
69,034 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2021-03-25 |
4 |
AS |
$1.56 |
$13,662 |
D/D |
(8,758) |
73,256 |
|
-28% |
|
Gibbs Michael Terrence |
General Counsel |
|
2021-03-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
82,014 |
|
- |
|
Pare Anthony |
Chief Commercial Officer |
|
2021-03-17 |
4 |
AS |
$1.84 |
$17,701 |
D/D |
(9,620) |
31,612 |
|
-47% |
|
Barclay Alec |
Chief Operations Officer |
|
2021-03-17 |
4 |
AS |
$1.86 |
$23,239 |
D/D |
(12,494) |
74,420 |
|
-47% |
|
Barclay Alec |
Chief Operations Officer |
|
2021-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,667 |
86,914 |
|
- |
|
Pare Anthony |
Chief Commercial Officer |
|
2021-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
41,232 |
|
- |
|
Barclay Alec |
Chief Operations Officer |
|
2021-02-24 |
4 |
D |
$0.45 |
$39,888 |
D/D |
(88,878) |
158,755 |
|
- |
|
Barclay Alec |
Chief Operations Officer |
|
2021-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
168,488 |
247,633 |
|
- |
|
Sprague John M |
Chief Financial Officer |
|
2021-02-23 |
4 |
AS |
$2.04 |
$10,710 |
D/D |
(5,250) |
35,485 |
|
-48% |
|
Barclay Alec |
Chief Operations Officer |
|
2021-02-23 |
4 |
AS |
$2.06 |
$14,997 |
D/D |
(7,280) |
65,247 |
|
-48% |
|
Gibbs Michael Terrence |
General Counsel |
|
2021-02-23 |
4 |
AS |
$2.06 |
$14,997 |
D/D |
(7,280) |
65,347 |
|
-48% |
|
Barclay Alec |
Chief Operations Officer |
|
2021-02-21 |
4 |
D |
$0.47 |
$2,458 |
D/D |
(5,275) |
79,145 |
|
- |
|
Barclay Alec |
Chief Operations Officer |
|
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
84,420 |
|
- |
|
Sprague John M |
Chief Financial Officer |
|
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
40,735 |
|
- |
|
Barclay Alec |
Chief Operations Officer |
|
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
72,527 |
|
- |
|
Gibbs Michael Terrence |
General Counsel |
|
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
72,627 |
|
- |
|
Elsbree David B |
Director |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,188 |
125,269 |
|
- |
|
Liebman Seymour |
Director |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,188 |
84,185 |
|
- |
|
Jones Adrian M |
Director |
|
2020-05-20 |
4 |
B |
$0.80 |
$4,116 |
I/I |
5,126 |
4,201,582 |
2.1 |
93% |
|
Goldman Sachs Group Inc/ |
10% Owner |
|
2020-05-20 |
4 |
B |
$0.80 |
$4,116 |
I/I |
5,126 |
4,201,582 |
1.42 |
93% |
|
349 Records found
|
|
Page 5 of 14 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|